Studies of Staphylococcus aureus FabI inhibitors: fragment-based approach based on holographic structure–activity relationship analyses (2017)
- Authors:
- USP affiliated authors: HONORIO, KÁTHIA MARIA - EACH ; WRENGER, CARSTEN - ICB ; TROSSINI, GUSTAVO HENRIQUE GOULART - FCF
- Unidades: EACH; ICB; FCF
- DOI: 10.4155/fmc-2016-0179
- Subjects: STAPHYLOCOCCUS; RELAÇÕES QUANTITATIVAS ENTRE ESTRUTURA QUÍMICA E ATIVIDADE BIOLÓGICA; MODELAGEM MOLECULAR
- Language: Inglês
- Imprenta:
- Source:
- Título: Future Medicinal Chemistry
- ISSN: 1756-8919
- Volume/Número/Paginação/Ano: v. 9, n. 2, p. 135-151, feb. 2017
- Status:
- Artigo possui versão em acesso aberto em repositório (Green Open Access)
- Versão do Documento:
- Versão submetida (Pré-print)
- Acessar versão aberta:
-
ABNT
KRONENBERGER, Thales et al. Studies of Staphylococcus aureus FabI inhibitors: fragment-based approach based on holographic structure–activity relationship analyses. Future Medicinal Chemistry, v. 9, n. 2, p. 135-151, 2017Tradução . . Disponível em: https://doi.org/10.4155/fmc-2016-0179. Acesso em: 02 abr. 2026. -
APA
Kronenberger, T., Asse Junior, L. R., Wrenger, C., Trossini, G. H. G., Honorio, K. M., & Maltarollo, V. G. (2017). Studies of Staphylococcus aureus FabI inhibitors: fragment-based approach based on holographic structure–activity relationship analyses. Future Medicinal Chemistry, 9( 2), 135-151. doi:10.4155/fmc-2016-0179 -
NLM
Kronenberger T, Asse Junior LR, Wrenger C, Trossini GHG, Honorio KM, Maltarollo VG. Studies of Staphylococcus aureus FabI inhibitors: fragment-based approach based on holographic structure–activity relationship analyses [Internet]. Future Medicinal Chemistry. 2017 ; 9( 2): 135-151.[citado 2026 abr. 02 ] Available from: https://doi.org/10.4155/fmc-2016-0179 -
Vancouver
Kronenberger T, Asse Junior LR, Wrenger C, Trossini GHG, Honorio KM, Maltarollo VG. Studies of Staphylococcus aureus FabI inhibitors: fragment-based approach based on holographic structure–activity relationship analyses [Internet]. Future Medicinal Chemistry. 2017 ; 9( 2): 135-151.[citado 2026 abr. 02 ] Available from: https://doi.org/10.4155/fmc-2016-0179 - Advances and challenges in drug design of PPARδ ligands
- Current trends in quantitative structure-activity relationship validation and applications on drug discovery
- On the relationship of anthranilic derivatives structure and the FXR (Farnesoid X receptor) agonist activity
- The role of QSAR and virtual screening studies in type 2 diabetes drug discovery
- Simulação do espectro de absorção UV do filtro solar p-metoxicinamato de etilexila empregando métodos teóricos (TD-DFT)
- Understanding PPAR-δ affinity and selectivity using hologram quantitative structure–activity modeling, molecular docking and GRID calculations
- Benchmark studies of UV-vis spectra simulation for cinnamates with UV filter profile
- In silico studies on the interaction between bioactive ligands and ALK5, a biological target related to the cancer treatment
- Use of machine learning approaches for novel drug discovery
- Indole-3-glyoxyl tyrosine: synthesis and antimalarial activity against Plasmodium falciparum
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
